Cite
HARVARD Citation
Pietrantonio, F. et al. (n.d.). HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research. International journal of cancer. 139 (12), pp. 2859-2864. [Online].